CellResearch Corporation (CRC) Announces Positive Results of Phase I Study For CorLiCyte®

CellResearch Corporation announced it has successfully closed the first Phase I study in CorLiCyte®, a stem cell therapy derived from umbilical cord lining stem cells, with research partners at the University of Colorado, Anschutz Medical Campus and ClinImmune Cell and Gene Therapy.
[CellResearch Corporation (PR Newswire)]
Press Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News